Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.
Tornado damage at a Pfizer Inc. PFE, +0.91% manufacturing facility in Rocky Mount, N.C., is threatening to make critical drug-supply shortages even worse, experts say.

3 Blue-Chip Stocks Trading at a Valuation Gap

08:44am, Thursday, 20'th Jul 2023
As the S&P 500 index trends higher, spotting undervalued blue-chip stocks is relatively challenging. A dovish fed and a declining possibility of a recession have supported an improvement in market sen
Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday after tornado damage to a U.S. facility owned by competitor Pfizer boosted other drugmakers' stock.
Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which boo

Pfizer plant in North Carolina damaged by tornado

06:56pm, Wednesday, 19'th Jul 2023
Drugmaker Pfizer Inc said on Wednesday its plant in Rocky Mount, North Carolina, which is one of the largest sterile injectable product facilities in the world, has suffered heavy damage from a tornad
A tornado heavily damaged a large Pfizer pharmaceutical plant in North Carolina on Wednesday, scattering medicine and other debris around the complex, a sheriff and the company said.

Readers Reveal 30 June Dividend Buys

05:05pm, Wednesday, 19'th Jul 2023
Prior to June 30, 2023, my readers mentioned 42 equities in their comments on my articles. Some bad-news investments (Rogues) mixed with (mostly) Favorites. Thus, these are ReFa/Ro. Ten analyst-target
Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.

Better Pharma Buy: Viatris vs. Pfizer

02:00pm, Wednesday, 19'th Jul 2023
Viatris has filled its pipeline with promising products -- that could add billions to revenue. Pfizer aims to launch a record number of drugs over the coming year or so.
Pfizer Inc (NYSE:PFE) and Flagship Pioneering have announced they will each invest an initial $50 million in a new partnership aimed at creating a new pipeline of innovative medicines targeting unmet
Pfizer Inc. PFE, -1.27% and Flagship Pioneering said Tuesday they are investing a total of $100 million upfront to explore opportunities to develop 10 single-asset programs within Pfizer's core areas
U.S. drugmaker Pfizer and venture capital firm Flagship Pioneering on Tuesday agreed to invest $100 million to discover and develop 10 new potential drugs targeting diseases with few or no treatment o
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In retirement, investors need income and stability. While bonds provide income, they might lack adequate appreciation to grow an investor's nest egg.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE